In the second installment of our Johns Hopkins series, hosts Dr. Steven Taback and Bill Curtis are joined by Dr. Ken Pienta, Professor of Urology, Oncology, Pharmacology, Molecular Sciences, and Director or Research for The James Buchanan Brady Urological Institute as he sheds light on the state of the art for treatment and outcomes of prostate cancer.
In this dedicated series, we're showcasing the medical breakthroughs & innovations from one of the world's most preeminent hospitals: Johns Hopkins Medicine.
Johns Hopkins Medicine is dedicated to improving the health of the community and the world by setting the standard of excellence in medical education, research, and clinical care.
1:46 What is it about Johns Hopkins that continues to produce top rankings and the gold standard for practice and research?
3:20 Does Johns Hopkins build their own robotics systems?
4:05 Why do so many of men still die from prostate cancer?
5:30 With prostate cancer numbers continually so high, why not prophylactically remove the prostate?
7:35 What are the signs men should look for the indicate prostate cancer?
8:37 What is the efficacy of the Prostate Specific Antigen (PSA) test, and what drawbacks does it have?
13:43 Is there a time to proceed with a biopsy without visible lesions from an MRI?
16:04 Proton Therapy and prostate cancer?
17:54 The use of radiation and hormone type therapy on younger men with prostate cancer
18:55 Incontinence and impotence post prostate treatment
20:30 Are there lifestyle changes one can make to prevent prostate cancer?
21:36 Immunotherapy and prostate cancer
22:54 What is the state of the art relative to testosterone and prostate cancer?
26:35 How depressed are the numbers for screening prostate cancer during the COVID pandemic, and what is the fallout to lack of testing?
Learn More: Medicine, We’re Still Practicing
Follow Us: Twitter | Facebook | Instagram
Hosted by: Dr. Steven Taback & Bill Curtis
Produced and Edited by: AJ Moseley
Sound Engineering by: Steve Reickeberg
Theme Music by: Celleste and Eric Dick
A CurtCo Media Production
See omnystudio.com/listener for privacy information.